Unitedhealth Group Incorporated Stock Filter Stocks by Fundamentals
| UNH Stock | USD 597.49 3.01 0.50% |
UnitedHealth Group Incorporated fundamentals help investors to digest information that contributes to UnitedHealth Group's financial success or failures. It also enables traders to predict the movement of UnitedHealth Stock. The fundamental analysis module provides a way to measure UnitedHealth Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to UnitedHealth Group stock.
UnitedHealth | Shares Owned by Institutions |
UnitedHealth Group ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, UnitedHealth Group's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to UnitedHealth Group's managers, analysts, and investors.Environmental | Governance | Social |
UnitedHealth Group Institutional Holders
Institutional Holdings refers to the ownership stake in UnitedHealth Group that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of UnitedHealth Group's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing UnitedHealth Group's value.| Shares | Capital Research & Mgmt Co - Division 3 | 2024-09-30 | 14.7 M | Norges Bank | 2024-06-30 | 11.7 M | Royal Bank Of Canada | 2024-06-30 | 8.5 M | Northern Trust Corp | 2024-09-30 | 8.4 M | Legal & General Group Plc | 2024-06-30 | 8.3 M | Wells Fargo & Co | 2024-06-30 | 8.2 M | Bank Of New York Mellon Corp | 2024-06-30 | 8 M | Alliancebernstein L.p. | 2024-06-30 | 7.9 M | Franklin Resources Inc | 2024-06-30 | 7.9 M | Vanguard Group Inc | 2024-09-30 | 85 M | Blackrock Inc | 2024-06-30 | 73.4 M |
UnitedHealth Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0692 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 593.51 B | ||||
| Shares Outstanding | 920.28 M | ||||
| Shares Owned By Insiders | 0.23 % | ||||
| Shares Owned By Institutions | 90.01 % | ||||
| Number Of Shares Shorted | 7.06 M | ||||
| Price To Earning | 26.34 X | ||||
| Price To Book | 5.85 X | ||||
| Price To Sales | 1.40 X | ||||
| Revenue | 371.62 B | ||||
| Gross Profit | 79.62 B | ||||
| EBITDA | 36.33 B | ||||
| Net Income | 22.38 B | ||||
| Cash And Equivalents | 27.91 B | ||||
| Cash Per Share | 45.51 X | ||||
| Total Debt | 67.44 B | ||||
| Debt To Equity | 0.59 % | ||||
| Current Ratio | 0.78 X | ||||
| Book Value Per Share | 102.42 X | ||||
| Cash Flow From Operations | 29.07 B | ||||
| Short Ratio | 2.20 X | ||||
| Earnings Per Share | 15.36 X | ||||
| Price To Earnings To Growth | 1.63 X | ||||
| Target Price | 623.93 | ||||
| Number Of Employees | 440 K | ||||
| Beta | 0.59 | ||||
| Market Capitalization | 549.86 B | ||||
| Total Asset | 278.42 B | ||||
| Retained Earnings | 95.77 B | ||||
| Working Capital | (20.62 B) | ||||
| Current Asset | 31.64 B | ||||
| Current Liabilities | 42.9 B | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.35 % | ||||
| Net Asset | 278.42 B | ||||
| Last Dividend Paid | 7.96 |
About UnitedHealth Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze UnitedHealth Group Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of UnitedHealth Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of UnitedHealth Group Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:Check out UnitedHealth Group Piotroski F Score and UnitedHealth Group Altman Z Score analysis. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.043 | Dividend Share 7.96 | Earnings Share 15.36 | Revenue Per Share 427.221 | Quarterly Revenue Growth 0.092 |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.